Total Payments
$1,576
2024 Payments
$800.48
Companies
23
Transactions
81
Medicare Patients
1,873
Medicare Billing
$193,442
Payment Breakdown by Category
Food & Beverage$1,520 (96.4%)
Education$56.10 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,520 | 77 | 96.4% |
| Education | $56.10 | 4 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $787.19 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $94.80 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $91.21 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $67.02 | 5 | $0 (2019) |
| IRONSHORE PHARMACEUTICALS INC. | $66.87 | 4 | $0 (2024) |
| Amgen Inc. | $64.01 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $47.93 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $45.15 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $43.62 | 2 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $37.35 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $800.48 | 38 | ABBVIE INC. ($331.02) |
| 2023 | $306.18 | 14 | ABBVIE INC. ($247.97) |
| 2022 | $152.68 | 10 | ABBVIE INC. ($129.43) |
| 2021 | $84.64 | 4 | AbbVie Inc. ($25.20) |
| 2020 | $53.57 | 3 | AbbVie Inc. ($53.57) |
| 2019 | $70.52 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39.24) |
| 2018 | $38.63 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27.78) |
| 2017 | $69.28 | 4 | Novartis Pharmaceuticals Corporation ($22.71) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.35 | General |
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/31/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/04/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/28/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 161 | 165 | $64,164 | $9,821 |
| 2021 | 8 | 786 | 1,074 | $329,017 | $99,194 |
| 2020 | 12 | 926 | 1,266 | $294,505 | $84,427 |
Total Patients
1,873
Total Services
2,505
Medicare Billing
$193,442
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 85 | $38,474 | $5,140 | 13.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $6,675 | $2,818 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 59 | $19,016 | $1,862 | 9.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 246 | 347 | $152,184 | $47,840 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 264 | 382 | $117,970 | $29,637 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 101 | 101 | $30,199 | $13,889 | 46.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 79 | $16,997 | $3,639 | 21.4% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 41 | 41 | $5,740 | $2,676 | 46.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 71 | $3,195 | $798.31 | 25.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $2,432 | $663.80 | 27.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 15 | $300.00 | $52.20 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 436 | 690 | $191,130 | $49,963 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 82 | 82 | $24,654 | $9,758 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 151 | 171 | $32,148 | $9,062 | 28.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 41 | $15,293 | $4,219 | 27.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 81 | 83 | $12,568 | $3,932 | 31.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 30 | 31 | $5,966 | $2,296 | 38.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 18 | 18 | $2,395 | $2,119 | 88.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 20 | 20 | $1,144 | $879.94 | 76.9% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 11 | 25 | $2,625 | $790.51 | 30.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 63 | $3,843 | $691.88 | 18.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 23 | 24 | $1,577 | $407.34 | 25.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 18 | 18 | $1,162 | $307.46 | 26.5% |
About Dr. Lorrie Oksenholt, DO
Dr. Lorrie Oksenholt, DO is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821261462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorrie Oksenholt, DO has received a total of $1,576 in payments from pharmaceutical and medical device companies, with $800.48 received in 2024. These payments were reported across 81 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,520).
As a Medicare-enrolled provider, Oksenholt has provided services to 1,873 Medicare beneficiaries, totaling 2,505 services with total Medicare billing of $193,442. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Roseburg, OR
- Active Since 04/03/2008
- Last Updated 03/13/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821261462
Products in Payments
- VRAYLAR (Drug) $563.52
- UBRELVY (Drug) $113.95
- LINZESS (Drug) $68.53
- JORNAY PM (Drug) $66.87
- KRYSTEXXA (Biological) $64.01
- CAPLYTA (Drug) $62.76
- BREZTRI (Drug) $58.93
- ABILIFY ASIMTUFII (Drug) $47.21
- Auvelity (Drug) $45.15
- SPIRIVA RESPIMAT (Drug) $42.21
- HETLIOZ (Drug) $37.35
- ABILIFY MAINTENA (Drug) $23.98
- TRULICITY (Drug) $23.25
- DUOPA (Drug) $23.16
- ENTRESTO (Drug) $22.71
- INGREZZA (Drug) $22.53
- Azstarys (Drug) $21.76
- ZURZUVAE (Drug) $21.23
- AIMOVIG (Biological) $20.91
- RYBELSUS (Drug) $20.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseburg
William Townsend, Md, MD
Internal Medicine — Payments: $3,059
Internal Medicine $3,059
Dr. Mohamed Abdel Khalek, M.d, M.D
Internal Medicine — Payments: $1,602
Internal Medicine $1,602
Joel Lee, Md, MD
Internal Medicine — Payments: $1,275
Internal Medicine $1,275
Doru Totoian, Md, MD
Internal Medicine — Payments: $1,266
Internal Medicine $1,266
Dr. Hennie Abrio, Md, MD
Internal Medicine — Payments: $970.03
Internal Medicine $970.03
Dr. Mukesh Thawani, M.d, M.D
Internal Medicine — Payments: $834.34
Internal Medicine $834.34